Qing Li
Chinese Academy of Sciences
4 Papers
7 Citations
Qing Li is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Coronary artery disease & Percutaneous coronary intervention. The author has an hindex of 3, co-authored 4 publications. Previous affiliations of Qing Li include Shanghai University.
Chat about Author
Papers
Effects of Shaoyao-Gancao Decoction on Infarcted Cerebral Cortical Neurons: Suppression of the Inflammatory Response following Cerebral Ischemia-Reperfusion in a Rat Model.
TL;DR: The mechanisms by which Shaoyao-Gancao decoction (SGD) inhibits the production of inflammatory cytokines in serum and brain tissue after cerebral ischemia-reperfusion (CI-RP) in rats were investigated and the efficacy of SGD was significantly higher than that of clopidogrel.
Cardiac Rehabilitation with Targeted Intensity Improves Cardiopulmonary Functions Accompanying with Reduced Copeptin Level in Patients with Coronary Artery Disease
Richard Y. Cao,Hongchao Zheng,Yi Hong,Yuntao Zheng,Yueyou Ding,Lifang Zhao,Hao Li,Qing Li,Wenchao Yuan,Shanshan Liu,Lezheng Wang,Jian Yang +11 more
TL;DR: Cardiac rehabilitation training improves cardiopulmonary exercise parameters El and PVO 2 which are correlated with reduced CPP level and may have a novel role in maintaining plasma osmolality and cardiovascular homeostasis.
10
Aerobic exercise-based cardiac rehabilitation in Chinese patients with coronary heart disease: study protocol for a pilot randomized controlled trial
TL;DR: This is the first prospective randomized and controlled clinical study in China that assesses the parameters of aerobic metabolism and comprehensively screens for substantial blood biomarkers to reveal the molecular mechanisms underlying changes in cardiovascular function after aerobic exercise with targeted intensity in participants with CHD.
The Emerging Role of MicroRNA-155 in Cardiovascular Diseases
Richard Y. Cao,Qing Li,Yi Miao,Ying Zhang,Wenchao Yuan,Li Fan,Gongliang Liu,Qiongyao Mi,Jian Yang +8 more
TL;DR: More comprehensive studies of the underlying mechanisms of microRNA-155 involvement in cardiovascular diseases are required, as a recent clinical trial of Miravirsen targeting micro RNA-122 sheds light on exploiting microRNAs as a novel target to develop effective therapeutic strategies for cardiovascular diseases in the near future.